Ogilvy prez denies wrongdoing in anti-drug ads

Published on .

Ogilvy & Mather executive Bill Gray, facing a call from the General Accounting Office about whether his agency committed fraud over billing for the White House's anti-drug advertising, issued a statement Oct. 4 denying any wrongdoing. "It is the policy of Ogilvy to ensure that billing for services is both fair and appropriate,'' said Mr. Gray, co-president of the agency's New York office. "We have charged [the anti-drug office] within the industry standard, and if we learn of any accounting problems, we will address them and make any necessary adjustments.'' Mr. Gray also said Ogilvy is pleased that its work for the office has contributed to the decline in teen drug use.

For more on the story, click here.

Copyright October 2000, Crain Communications Inc.

Most Popular
In this article: